Yahoo Web Search

Search results

    • Weight-loss injections could halve risk of cancer

      Weight-loss injections could halve risk of cancer

      The Telegraph via Yahoo News· 3 days ago

      The GLP-1 agonist drugs, which are licensed to treat obesity and diabetes, could revolutionise cancer care after studies found they reduced the risk of...

    • Is Viking Therapeutics Stock a Buy on the Dip?

      Is Viking Therapeutics Stock a Buy on the Dip?

      The Motley Fool via AOL· 1 day ago

      The reason? Investors have flocked to the biotech stock in response to its experimental weight loss therapy, VK2735. This is a peptide GLP-1/GIP dual ...